Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 16, 2015 - Issue 1-2
Submit an article Journal homepage
269
Views
5
CrossRef citations to date
0
Altmetric
CLINICAL

Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor

Antonio CanosaALS Centre, ‘Rita Levi Montalcini’ Department of Neuroscience, University of Torino, Turin, Italy;Department of Neuroscience, Ophthalmology, Genetics, Rehabilitation and Child Health, University of Genova, Genoa, ItalyCorrespondence[email protected]
,
Andrea CalvoALS Centre, ‘Rita Levi Montalcini’ Department of Neuroscience, University of Torino, Turin, Italy;Neurologia 2, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy;Neuroscience Institute of Torino, Turin, Italy
,
Marco BarberisALS Centre, ‘Rita Levi Montalcini’ Department of Neuroscience, University of Torino, Turin, Italy;Laboratory of Molecular Genetics, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
,
Maura BrunettiALS Centre, ‘Rita Levi Montalcini’ Department of Neuroscience, University of Torino, Turin, Italy;Laboratory of Molecular Genetics, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
,
Gabriella RestagnoLaboratory of Molecular Genetics, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
,
Stefania CammarosanoALS Centre, ‘Rita Levi Montalcini’ Department of Neuroscience, University of Torino, Turin, Italy
,
Antonio IlardiALS Centre, ‘Rita Levi Montalcini’ Department of Neuroscience, University of Torino, Turin, Italy
,
Maria C. ViglianiNeurologia 2, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
,
Adriano ChiòALS Centre, ‘Rita Levi Montalcini’ Department of Neuroscience, University of Torino, Turin, Italy;Neurologia 2, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Turin, Italy;Neuroscience Institute of Torino, Turin, Italy
&
Cristina MogliaALS Centre, ‘Rita Levi Montalcini’ Department of Neuroscience, University of Torino, Turin, Italy
 show all
Pages 129-130 | Received 06 Jun 2014, Accepted 20 Sep 2014, Published online: 22 Oct 2014

References

  • Renton AE, Chiò A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17–23.
  • Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001;28:131–8.
  • Pronto-Laborinho ACI, Pinto SI, de Carvalho M. Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis. Biomed Res Int. 2014;2014:947513. doi: 10.1155/2014/947513. Epub 2014 Apr 29.
  • Jonasch E, Signorovitch JE, Lin PL, Liu Z, Culver K, Pal SK, et al. Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices. Curr Med Res Opin. 2014;9:1–10.
  • Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, et al. Sunitinib versus interferon-alpha in metastatic renal-cell carcinoma. N Engl J Med. 2007;356:115–24.
  • Motzer RJ, Hutson TE, Cella D, Reeves J, Hawkins R, Guo J, et al. Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med. 2013;369:722–31.
  • Aparicio-Gallego G, Blanco M, Figueroa A, García-Campelo R, Valladares-Ayerbes M, Grande-Pulido E, et al. New insights into molecular mechanisms of sunitinib-associated side-effects. Mol Cancer Ther. 2011;10:2215–23.
  • Evans BK, Fagan C, Arnold T, Dropcho EJ, Oh SJ. Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurology. 1990;40:960–2.
  • Mendel DB, Laird AD, Xin X, Louie SG, Christensen JG, Li G, et al. In vivo anti-tumour activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res. 2003;9:327–37.
  • Sanchez A, Tripathy D, Yin X, Luo J, Martinez JM, Grammas P. Sunitinib enhances neuronal survival in vitro via NF-κB-mediated signalling and expression of cyclooxygenase-2 and inducible nitric oxide synthase. J Neuroinflammation. 2013;10:93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.